April 30, 2018
The Novartis bribery scandal widens: a whistleblower has alleged that the company bribed doctors in China to prescribe its products, masking the bribes through fake medical events. Meanwhile, a special prosecutor will lead the probe into the Novartis bribery allegations in Greece after a parliamentary committee found itself unable to conduct the investigation effectively.
In other news, Dun & Bradstreet agreed to pay US$9.2 million to settle the SEC’s six-year investigation into alleged FCPA violations stemming from two indirect Chinese subsidiaries. And Brazil’s ex-president Lula da Silva surrendered himself (and likely his hopes of ever again becoming President) to begin serving his 12-year jail sentence for corruption in connection with the Petrobras graft scheme.
Visit the TRACE Compendium to view the complete entries, along with other updates from this month.